⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30289991 | 0.77 | KDM4E (0.38) | — | |
| SCHEMBL4317322 | 0.76 | — | — | |
| SCHEMBL3382388 | 0.76 | — | — | |
| SCHEMBL3382387 | 0.76 | — | — | |
| SCHEMBL3315313 | 0.76 | — | — | |
| SCHEMBL7528412 | 0.76 | — | — | |
| SCHEMBL3315309 | 0.76 | — | — | |
| SCHEMBL22383997 | 0.75 | ENPEP (0.39) | — | |
| SCHEMBL3513292 | 0.74 | PTGS1 (0.40) | — | |
| SCHEMBL11711858 | 0.74 | GPR84 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008090534-A1 | METHODS AND COMPOSITIONS FOR INHIBITION OF EXCESSIVE WEIGHT GAIN, REDUCTION OF INAPPROPRIATE EATING BEHAVIOURS AND INHIBITION OF BINGE EATING FOR THE TREATMENT OF OBESITY | BERAND LIMITED (IE) | 2008-07-31 | — | — | WO | claimed |
| WO-2007049262-A1 | Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders | BERAND LIMITED (IE) | 2007-05-03 | — | — | WO | claimed |
| EP-4397970-A2 | MUTANT PORE | Oxford Nanopore Technologies PLC (GB) | 2024-07-10 | — | — | EP | disclosed |
| EP-4122949-B1 | MUTANT PORE | OXFORD NANOPORE TECH PLC (GB) | 2024-06-05 | — | — | EP | disclosed |
| WO-2024094986-A1 | METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-05-10 | — | — | WO | disclosed |
| US-11939359-B2 | Mutant pore | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-03-26 | — | — | US | disclosed |
| US-20240076729-A9 | METHOD | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-03-07 | — | — | US | disclosed |
| US-11920193-B2 | Method of characterizing a polynucleotide | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-03-05 | — | — | US | disclosed |
| US-20240044865-A1 | METHOD OF CHARACTERISING A TARGET POLYPEPTIDE USING A NANOPORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-02-08 | — | — | US | disclosed |
| US-20230408408-A1 | METHOD OF DETECTING AN ANALYTE IN A MEDIUM COMPRISING A LIGHT SCATTERING CONSTITUENT | KING'S COLLEGE LONDON (GB) | 2023-12-21 | — | — | US | disclosed |
| WO-2023222657-A1 | METHOD AND ADAPTORS | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-11-23 | — | — | WO | disclosed |
| WO-2008053484-A2 | PREPARATION OF HEAVY METAL-CONTAINING NANO-LIPOSOMES AND THEIR USES IN MEDICAL THERAPY | S.B. BIOTECHNOLOGIES LTD. (IL) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008001109-A2 | METHOD OF COVALENTLY LINKING A CARBOHYDRATE OR POLYALKYLENE OXIDE TO A PEPTIDE, PRECURSORS FOR USE IN THE METHOD AND RESULTANT PRODUCTS | UCL BUSINESS PLC (GB) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007049262-A1 | Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders | BERAND LIMITED (IE) | 2007-05-03 | — | — | WO | disclosed |
| US-20070087446-A1 | Aromatic phosphonium salts and their use as labeling reagents in mass spectrometry analysis | WATERS INVESTMENTS LIMITED (US) | 2007-04-19 | — | — | US | disclosed |
| WO-2004092707-A2 | AROMATIC PHOSPHONIUM SALTS AND THEIR USE AS LABELING REAGENTS MASS SPECTROMETRY ANALYSIS | WATERS INVESTMENTS LIMITED (US) | 2004-10-28 | — | — | WO | disclosed |
| US-6022522-A | DETECTABLY LABELED BICONJUGATE COMPOUND WHICH COMPRISES A MONOCLONAL ANTIBODY AND A TECHTINIUM-99M COUPLED TO A CHELATING AGENT HAVING A RIGID CYCLIC HYDROCARBON BACKBONE OF GIVEN FORMULA, COUPLED TO THE MONOCLONAL ANTIBODY | BROOKHAVEN SCIENCE ASSOCIATES (US) | 2000-02-08 | — | — | US | disclosed |
| US-5783169-A | RADIOIMMUNOCONJUGATED; DIAGNOSTIC AND THERAPY | BROOKHAVEN SCIENCE ASSOCIATES LLC (US) | 1998-07-21 | — | — | US | disclosed |
| US-4663481-A | BROMINATION | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-05-05 | — | — | US | disclosed |
| EP-0144177-A1 | Preparation of bromoacetamides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-06-12 | — | — | EP | disclosed |